Wonkyung Byon

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 282 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Vijay Upreti, Jessie Wang, Yu Chen Barrett et al. · British Journal of Clinical Pharmacology · 2013 · 269 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

Wonkyung Byon, P Chan, MA Tortorici et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 190 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Ming Chang, Zhigang Yu, Andrew Shenker et al. · The Journal of Clinical Pharmacology · 2015 · 172 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

John W. Stanifer, Sean D. Pokorney, Glenn M. Chertow et al. · Circulation · 2020 · 164 citations

Pharmacy, Pharmacology, Pharmacotherapy +15